News | August 02, 2025
USPTO issues final rejection of Rampart IC's radiation shield patent claims
The request stemmed from a 2024 lawsuit by Rampart alleging Egg Medical had infringed its patent
The request stemmed from a 2024 lawsuit by Rampart alleging Egg Medical had infringed its patent
The newly inaugurated facility bridges this gap by offering metro-grade treatment closer to home
Collaboration to provide hospitals with a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy
It also secures US $ 10 million for US launch and commercialization
These aprons utilise phase change materials that absorb, store and release heat for optimal thermal comfort
cSCC is one of the most common cancers in the U.S. and globally
Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
The new facility combines advanced technology, enhanced capacity, and holistic care, reaffirming HCG’s commitment to accessible, world-class oncology in Gujarat
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
Will add UNLOXCYT (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for metastatic or locally advanced cutaneous squamous cell carcinoma (cSCC) to Sun Pharma's global onco-derm franchise
Subscribe To Our Newsletter & Stay Updated
